K083764

Substantially Equivalent

AMPHETAMINES II

Applicant: Roche Diagnostics Corp.
Product code: DKZ
Advisory panel: Clinical Toxicology
Date received: 2008-12-18
Decision date: 2010-02-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.